{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:48:31Z","timestamp":1790840911371,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.chest.2018.12.011","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T12:17:47Z","timestamp":1547727467000},"page":"1026-1040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Integrating Genomics Into Management of\u00a0Fibrotic Interstitial Lung Disease"],"prefix":"10.1016","volume":"155","author":[{"given":"Ayodeji","family":"Adegunsoye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Vij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Noth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2018.12.011_bib1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.chest.2016.07.027","article-title":"Therapeutic approach to adult fibrotic lung diseases","volume":"150","author":"Adegunsoye","year":"2016","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2018.12.011_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJMoa1007285","article-title":"Lung volumes and emphysema in smokers with interstitial lung abnormalities","volume":"364","author":"Washko","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.chest.2018.12.011_bib3","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1056\/NEJMoa1216076","article-title":"MUC5B promoter polymorphism and interstitial lung abnormalities","volume":"368","author":"Hunninghake","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib4","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1183\/13993003.00129-2016","article-title":"High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study","volume":"48","author":"Podolanczuk","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1164\/rccm.200812-1966OC","article-title":"Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study","volume":"180","author":"Lederer","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2018.12.011_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/resp.12466","article-title":"MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis","volume":"20","author":"Horimasu","year":"2015","journal-title":"Respirology"},{"issue":"8","key":"10.1016\/j.chest.2018.12.011_bib7","doi-asserted-by":"crossref","first-page":"e70621","DOI":"10.1371\/journal.pone.0070621","article-title":"The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population","volume":"8","author":"Borie","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.chest.2018.12.011_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00537-2017","article-title":"The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes","volume":"50","author":"Putman","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2018.12.011_bib9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.chest.2017.04.185","article-title":"Clinical and genetic associations of objectively identified interstitial changes in smokers","volume":"152","author":"Ash","year":"2017","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2018.12.011_bib10","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1164\/rccm.201512-2523OC","article-title":"Development and progression of interstitial lung abnormalities in the Framingham Heart Study","volume":"194","author":"Araki","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2018.12.011_bib11","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.rmed.2011.08.022","article-title":"Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis","volume":"105","author":"Garcia-Sancho","year":"2011","journal-title":"Respir Med"},{"issue":"13","key":"10.1016\/j.chest.2018.12.011_bib12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa066157","article-title":"Telomerase mutations in families with idiopathic pulmonary fibrosis","volume":"356","author":"Armanios","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib13","doi-asserted-by":"crossref","first-page":"e10680","DOI":"10.1371\/journal.pone.0010680","article-title":"Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations","volume":"5","author":"Diaz de Leon","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ng.3278","article-title":"Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening","volume":"47","author":"Stuart","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.chest.2018.12.011_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fmed.2017.00154","article-title":"Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis, and treatment","volume":"4","author":"Kaur","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"10.1016\/j.chest.2018.12.011_bib16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S2213-2600(17)30216-3","article-title":"The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study","volume":"5","author":"Ley","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"23","key":"10.1016\/j.chest.2018.12.011_bib17","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.chest.2018.12.011_bib18","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1164\/rccm.201505-1010OC","article-title":"TOLLIP, MUC5B, and the response to n-acetylcysteine among individuals with idiopathic pulmonary fibrosis","volume":"192","author":"Oldham","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2018.12.011_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S2213-2600(13)70045-6","article-title":"Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study","volume":"1","author":"Noth","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"21","key":"10.1016\/j.chest.2018.12.011_bib20","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.2013.5827","article-title":"Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis","volume":"309","author":"Peljto","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chest.2018.12.011_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2609","article-title":"Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis","volume":"45","author":"Fingerlin","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.chest.2018.12.011_bib22","unstructured":"(US) NLoM. Genetics Home Reference [Internet]. Bethesda (MD). The Library. Accessed August 18, 2018."},{"issue":"1","key":"10.1016\/j.chest.2018.12.011_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1164\/rccm.201610-2088OC","article-title":"An exome sequencing study to assess the role of rare genetic variation in pulmonary fibrosis","volume":"196","author":"Petrovski","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"144","key":"10.1016\/j.chest.2018.12.011_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0122-2016","article-title":"Management of suspected monogenic lung fibrosis in a specialised centre","volume":"26","author":"Borie","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"suppl 1","key":"10.1016\/j.chest.2018.12.011_bib25","first-page":"1","article-title":"Genetics of interstitial lung disease: vol de nuit (night flight)","volume":"9","author":"Furukawa","year":"2015","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"issue":"1","key":"10.1016\/j.chest.2018.12.011_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.rmed.2013.11.004","article-title":"Genetic susceptibility to multicase hypersensitivity pneumonitis is associated with the TNF-238 GG genotype of the promoter region and HLA-DRB1*04 bearing HLA haplotypes","volume":"108","author":"Falfan-Valencia","year":"2014","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2018.12.011_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12863-016-0377-2","article-title":"Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia","volume":"17","author":"Fingerlin","year":"2016","journal-title":"BMC Genet"},{"issue":"19","key":"10.1016\/j.chest.2018.12.011_bib28","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2018.12.011_bib29","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1183\/09031936.00163814","article-title":"The genetic basis of idiopathic pulmonary fibrosis.","volume":"45","author":"Kropski","year":"2015","journal-title":"Eur Respir J."},{"issue":"2","key":"10.1016\/j.chest.2018.12.011_bib30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1378\/chest.14-0867","article-title":"The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries","volume":"147","author":"Peljto","year":"2015","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.chest.2018.12.011_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S2213-2600(17)30387-9","article-title":"Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study","volume":"5","author":"Allen","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2018.12.011_bib32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","article-title":"Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive","volume":"48","author":"Newton","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2018.12.011_bib33","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1378\/chest.13-2224","article-title":"A\u00a0novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia","volume":"146","author":"Kropski","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.chest.2018.12.011_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12916-015-0434-0","article-title":"Incorporating genetics into the identification and treatment of idiopathic pulmonary fibrosis","volume":"13","author":"Mathai","year":"2015","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.chest.2018.12.011_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/rccm.201408-1510OC","article-title":"Rare variants in RTEL1 are associated with familial interstitial pneumonia","volume":"191","author":"Cogan","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2018.12.011_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tcb.2014.01.004","article-title":"RTEL1: functions of a disease-associated helicase","volume":"24","author":"Vannier","year":"2014","journal-title":"Trends Cell Biol"},{"issue":"4","key":"10.1016\/j.chest.2018.12.011_bib37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2012.03.030","article-title":"RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity","volume":"149","author":"Vannier","year":"2012","journal-title":"Cell"},{"issue":"6155","key":"10.1016\/j.chest.2018.12.011_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1241779","article-title":"RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication","volume":"342","author":"Vannier","year":"2013","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.chest.2018.12.011_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/resp.12234","article-title":"Predictors of mortality in rheumatoid arthritis-related interstitial lung disease","volume":"19","author":"Assayag","year":"2014","journal-title":"Respirology"},{"issue":"9","key":"10.1016\/j.chest.2018.12.011_bib40","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00545-2017","article-title":"A\u00a0recurring theme in pulmonary fibrosis genetics","volume":"49","author":"Wolters","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2018.12.011_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.rmed.2017.03.027","article-title":"High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: relationship to survival","volume":"126","author":"Yunt","year":"2017","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02314-2016","article-title":"Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jmg.2010.085100","article-title":"Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita","volume":"48","author":"Parry","year":"2011","journal-title":"J\u00a0Med Genet"},{"issue":"11","key":"10.1016\/j.chest.2018.12.011_bib45","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1164\/rccm.201609-1820PP","article-title":"Genetic evaluation and testing of patients and families with idiopathic pulmonary fibrosis","volume":"195","author":"Kropski","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2018.12.011_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-genom-082908-150046","article-title":"Syndromes of telomere shortening","volume":"10","author":"Armanios","year":"2009","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"1","key":"10.1016\/j.chest.2018.12.011_bib47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1183\/09031936.00060014","article-title":"Lung transplantation in telomerase mutation carriers with pulmonary fibrosis","volume":"44","author":"Silhan","year":"2014","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2018.12.011_bib48","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/humu.23566","article-title":"Targeted resequencing reveals genetic risks in patients with sporadic idiopathic pulmonary fibrosis","volume":"39","author":"Deng","year":"2018","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.chest.2018.12.011_bib49","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1152\/physrev.00004.2016","article-title":"Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways","volume":"96","author":"Evans","year":"2016","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib50","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"10.1016\/j.chest.2018.12.011_bib51","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A\u00a0common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/thoraxjnl-2012-201786","article-title":"Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis","volume":"68","author":"Stock","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2018.12.011_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.rmed.2017.07.010","article-title":"Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis","volume":"130","author":"Johnson","year":"2017","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.chest.2018.12.011_bib54","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S2213-2600(18)30135-8","article-title":"Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study","volume":"6","author":"Dressen","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.chest.2018.12.011_bib55","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1164\/rccm.201312-2219PP","article-title":"Genetics and early detection in idiopathic pulmonary fibrosis","volume":"189","author":"Putman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2018.12.011_bib56","series-title":"The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF). NCT00075998. ClinicalTrials.gov","author":"InterMune","year":"2004"},{"issue":"4","key":"10.1016\/j.chest.2018.12.011_bib57","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201203-0513CI","article-title":"Hypersensitivity pneumonitis: insights in diagnosis and pathobiology","volume":"186","author":"Selman","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2018.12.011_bib58","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1183\/13993003.00829-2015","article-title":"Connective tissue diseases, multimorbidity and the ageing lung","volume":"47","author":"Spagnolo","year":"2016","journal-title":"Eur Respir J"},{"issue":"35","key":"10.1016\/j.chest.2018.12.011_bib59","doi-asserted-by":"crossref","first-page":"13051","DOI":"10.1073\/pnas.0804280105","article-title":"Short telomeres are a risk factor for idiopathic pulmonary fibrosis","volume":"105","author":"Alder","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.chest.2018.12.011_bib60","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1378\/chest.14-3078","article-title":"Telomere length in interstitial lung diseases","volume":"148","author":"Snetselaar","year":"2015","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2018.12.011_bib61","doi-asserted-by":"crossref","first-page":"e0189467","DOI":"10.1371\/journal.pone.0189467","article-title":"Short telomere length in IPF lung associates with fibrotic lesions and predicts survival","volume":"12","author":"Snetselaar","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.chest.2018.12.011_bib62","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.healun.2017.02.005","article-title":"Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival","volume":"36","author":"Newton","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.chest.2018.12.011_bib63","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(14)70124-9","article-title":"Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation","volume":"2","author":"Stuart","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.chest.2018.12.011_bib64","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2018.12.011_bib65","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1378\/chest.14-0631","article-title":"Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease","volume":"147","author":"George","year":"2015","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2018.12.011_bib66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.chest.2017.09.026","article-title":"Phenotypic clusters predict outcomes in a longitudinal interstitial lung disease cohort","volume":"153","author":"Adegunsoye","year":"2018","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2018.12.011_bib67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.201802-0306ED","article-title":"\u00a1HOLA! The influence of being Hispanic on lung ancestry","volume":"198","author":"Cho","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2018.12.011_bib68","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00255-2018","article-title":"African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis","volume":"51","author":"Adegunsoye","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2018.12.011_bib69","doi-asserted-by":"crossref","unstructured":"Adegunsoye A, Oldham JM, Bonham C, et\u00a0al. Prognosticating outcomes in interstitial lung disease by mediastinal lymph node assessment: an observational cohort study with independent validation [published online ahead of print September 14, 2018]. Am J Respir Crit Care Med. doi:10.1164\/rccm.201804-0761OC.","DOI":"10.1164\/rccm.201804-0761OC"},{"issue":"4","key":"10.1016\/j.chest.2018.12.011_bib70","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1378\/chest.14-3218","article-title":"Development of novel agents for idiopathic pulmonary fibrosis: progress in target selection and clinical trial design","volume":"148","author":"O'Riordan","year":"2015","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2018.12.011_bib71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chest.2016.10.029","article-title":"Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis","volume":"151","author":"Morisset","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2018.12.011_bib72","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1038\/s41598-018-24303-4","article-title":"Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"8","author":"Biondini","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.chest.2018.12.011_bib73","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.healun.2015.05.002","article-title":"Clinical outcomes of lung transplant recipients with telomerase mutations","volume":"34","author":"Tokman","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.chest.2018.12.011_bib74","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.healun.2014.11.010","article-title":"Severe hematologic complications after lung transplantation in patients with telomerase complex mutations","volume":"34","author":"Borie","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219300017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219300017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:08:53Z","timestamp":1757923733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369219300017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0012369219300017"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2018.12.011","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Genomics Into Management of\u00a0Fibrotic Interstitial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2018.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}